EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome

Mototaka Sato(Osaka University), Norio Nonomura(The University of Osaka)
PLoS ONE
September 20, 2013
Cited by 46


Related Papers